Evidence map›Paper›PMID 42665811›Full record

ReviewJournal of translational medicine2026

Agentic systems in computational pathology: architectures, evidence, and translational challenges.

Xinyu Lu, Qiankun Li, Yakun Gao, Wei Dong, Mengyao Lyu, Siyuan Ma, Jinyue Li, Yufeng Wu, Linghan Cai, Tianyi Zhang and 4 more

Abstract readReview
In one paragraph

Review in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Xinyu Lu *Third Department of Hepatic Surgery, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai, 200438, China.
Qiankun Li *College of Computing and Data Science, Nanyang Technological University, Singapore, 639798, Singapore.
Yakun Gao *Department of Plastic Surgery, Huashan Hospital, Fudan University, Shanghai, 200040, China.
Wei DongThird Department of Hepatic Surgery, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai, 200438, China.
Mengyao LyuCollege of Computing and Data Science, Nanyang Technological University, Singapore, 639798, Singapore.
Siyuan MaCollege of Computing and Data Science, Nanyang Technological University, Singapore, 639798, Singapore.
Jinyue LiCollege of Computing and Data Science, Nanyang Technological University, Singapore, 639798, Singapore.
Yufeng WuPuzzleLogic Pte Ltd, 1 Claymore Drive, Singapore, 229594, Singapore.
Linghan CaiPuzzleLogic Pte Ltd, 1 Claymore Drive, Singapore, 229594, Singapore.
Tianyi ZhangDepartment of Electrical and Computer Engineering, National University of Singapore, Singapore, 117583, Singapore.
Shangqing LyuPuzzleLogic Pte Ltd, 1 Claymore Drive, Singapore, 229594, Singapore.
Zeyu LiuPuzzleLogic Pte Ltd, 1 Claymore Drive, Singapore, 229594, Singapore. zeyuliu@puzzlelogic.com.
Hui LiuThird Department of Hepatic Surgery, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai, 200438, China. liuhuigg23@163.com.
Susu LuoThird Department of Hepatic Surgery, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai, 200438, China. tingluo@wustl.edu.ORCID 0000-0001-9353-3671

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDigital pathology supports whole-slide imaging, remote review, and computational analysis. Most pathology AI systems, however, remain restricted to predefined tasks. Agentic architectures coordinate perception models, language-based reasoning, external tools, and feedback-dependent actions, but their clinical evidence is derived mainly from retrospective benchmarks and research prototypes. MAIN BODY: We review agentic systems in computational pathology using an operational taxonomy based on dynamic control flow, inference-time tool selection, and knowledge integration. We assess architectures, enabling technologies, and applications in diagnosis, prognosis, and therapeutic support. Reported gains are difficult to attribute to agentic organization because studies differ in backbones, training data, and inference budgets. We therefore emphasize validation scope, computational cost, workflow integration, hallucination and security risks, regulatory requirements, patient preferences, and the conditions under which specialist non-agentic models remain preferable.

conclusionsAgentic architectures have established technical feasibility, but not clinical benefit. Translation should prioritize verifiable tasks, matched comparisons, prospective and external validation, lifecycle governance, and interfaces that preserve pathologist oversight.

Indexed as

PathologyTranslational Research, BiomedicalArtificial IntelligenceHumansAgentic artificial intelligenceDigital pathologyLarge language modelsWhole-slide imaging

Identifiers

PMID42665811
PMCPMC13525681

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.